IsoRay Inc. | |
Stock Exchange | NYSE |
EPS |
$0.1 |
Market Cap |
$27.64 M |
Shares Outstanding |
67.34 M |
Public Float |
66.62 M |
Address |
350 Hills Street Richland Washington 99354 United States |
Employees | - |
Website | http://www.isoray.com |
Updated | 07/08/2019 |
IsoRay, Inc. is a medical technology company. Though its subsidiary IsoRay Medical, Inc., it develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. Its product include Cesium-131 (Cs-131), a radioisotope for the treatment of prostate cancer, brain cancer, breast cancer, colorectal cancer, gynecological cancer, lung cancer, liver cancer, ocular melanoma, and pancreatic cancer. |